health pharma news today obesity drugs glp-1 Giants Bet on Next-Generation Treatments to Sustain Growth Eli Lilly obesity pill Foundayo
Description
Glucagon-like peptide 1 receptor agonists and heart failure: The need for further evidence generation and practice guidelines optimization
DPP-IV-Resistant, Long-Acting Oxyntomodulin Derivatives
doi: 10.1177/19322968221147937
(2021) evaluated the effects of the GLP-1R agonist Ex4 (2.4 g/kg) on heroin-seeking behavior in a rat model using a reward devaluation paradigm [62]
